Cervical Cancer Vaccine Quadrivalent Vaccination Age

Cervical cancer vaccine 4-valent vaccine is suitable for women aged 9 to 45 years old, and after vaccination, it is necessary to pay attention to a light diet and keep the vaccination site dry.
Cervical Cancer Vaccine 4-valent vaccine prevents HPV infections of types 6, 11, 16, and 18 It can effectively reduce the incidence of cervical cancer, and is suitable for women aged 9 to 45 years old. The vaccine needs to be given three times and is completed in about 6 months. It is not recommended for women who have a cold or are breastfeeding, and they should be kept under observation for about 15 minutes after vaccination.
Fever, fatigue, myalgia, and headache are common adverse reactions; hypersensitivity to the active ingredient or excipients of the product is contraindicated, and those who have had a hypersensitivity reaction to an injection of the product should not be revaccinated with the product.
It is recommended to avoid pregnancy for 3 to 6 months after vaccination. Although the incidence of cervical cancer is reduced after vaccination, personal hygiene and regular checkups should be maintained in daily life.